Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Cardiovascular Health Supplements Market

Cardiovascular Health Supplements Market Trends

Report ID: GMI7158
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Cardiovascular Health Supplements Market Trends

The increasing cases of cardiovascular diseases is a significant driver for the growth of the market. Cardiovascular diseases including heart attacks and strokes continue to be leading causes of morbidity and mortality worldwide. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2021, over 695,000 people in the U.S. died from heart disease, recorded as 1 out of every 5 deaths.
As a result, with heart-related conditions becoming more prevalent, individuals increasingly seek preventive measures. Therefore, adoption of cardiovascular health supplements may offer a convenient solution, providing essential nutrients. Thus, expanding the growth of the market.
While these supplements offer potential benefits for heart health, their affordability poses a challenge, especially for individuals with limited financial resources. High prices may deter people from purchasing or consistently using these supplements, limiting access to essential nutrients that could aid in cardiovascular health.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cardiovascular health supplements industry size was over USD 9 billion in 2022 and is expected to reach USD 19.4 billion by 2032, favored by the increasing awareness towards a healthy lifestyle, ageing geriatric population, and growing R&D in the field of supplements.

In the year 2022, natural supplements segment held a substantial market share of 69.3%. The factors such as ease of availability & accessibility, safety, and minimal side effects makes natural supplements the preferred choice for many individuals.

North America cardiovascular health supplements market is expected to grow at 7.4% during 2023 and 2032, as the region is equipped with highly advanced healthcare infrastructure, with robust pharmaceutical and supplement sectors, along with a surge in cardiovascular cases & related health challenges.

Herbalife International of America, Inc., Sanofi S.A., Nestle, Amway, Nature's Way Products, Inc, InVite Health, Nordic Naturals, Thorne HealthTech, Inc., GNC Holdings, Inc, NOW Health Group, Inc., and USANA Health Sciences.